These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Physiopathology of refractory ascites and the hepatorenal syndrome]. Arroyo V Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916 [No Abstract] [Full Text] [Related]
4. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention? Møller S; Henriksen JH Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398 [TBL] [Abstract][Full Text] [Related]
5. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes. Møller S; Krag A; Bendtsen F Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771 [TBL] [Abstract][Full Text] [Related]
6. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. Epstein M J Am Soc Nephrol; 1994 Apr; 4(10):1735-53. PubMed ID: 8068872 [TBL] [Abstract][Full Text] [Related]
7. Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function. Cade R; Wagemaker H; Vogel S; Mars D; Hood-Lewis D; Privette M; Peterson J; Schlein E; Hawkins R; Raulerson D Am J Med; 1987 Mar; 82(3):427-38. PubMed ID: 3548346 [TBL] [Abstract][Full Text] [Related]
8. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial. Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W Crit Care; 2008; 12(1):R4. PubMed ID: 18197961 [TBL] [Abstract][Full Text] [Related]
9. [Hepatorenal syndrome]. Mancini E G Ital Nefrol; 2012; 29(5):563-78. PubMed ID: 23117737 [TBL] [Abstract][Full Text] [Related]
11. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. Gentilini P; Laffi G; La Villa G; Raggi VC Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019 [TBL] [Abstract][Full Text] [Related]
12. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy. Arroyo V Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiology, clinical features and management of hepatorenal syndrome. Garzia P; Ferri GM; Ilardi M; Messina FR; Amoroso A Eur Rev Med Pharmacol Sci; 1998; 2(5-6):181-4. PubMed ID: 10710816 [TBL] [Abstract][Full Text] [Related]
14. Hepatorenal syndrome. Guevara M; Ginès P Dig Dis; 2005; 23(1):47-55. PubMed ID: 15920325 [TBL] [Abstract][Full Text] [Related]
16. Terlipressin in hepatorenal syndrome: Evidence for present indications. Rajekar H; Chawla Y J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521 [TBL] [Abstract][Full Text] [Related]
17. Organ interactions in the hepatorenal syndrome. Neuschwander-Tetri BA New Horiz; 1994 Nov; 2(4):527-44. PubMed ID: 7804802 [TBL] [Abstract][Full Text] [Related]
18. New treatments of hepatorenal syndrome. Arroyo V; Terra C; Ginès P Semin Liver Dis; 2006 Aug; 26(3):254-64. PubMed ID: 16850375 [TBL] [Abstract][Full Text] [Related]
19. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914 [TBL] [Abstract][Full Text] [Related]